Cogstate (ASX:CGS): Winning brain health trials and investing in AI to scale
Transcription of The Stock Network Interview with Cogstate (ASX:CGS), Managing Director CEO and Managing Director Brad O’Connor Lel Smits: Cogstate is helping drug developers measure how new medicines affect the brain in clinical trials, supplying the cognitive tests, rater training, and data checks behind studies in Alzheimer’s disease, sleep, rare disease, and psychiatry. The company […]
Tasmea (ASX:TEA): Record results on back of powering electrification & data centres across Australia
Transcription of The Stock Network Interview with Tasmea (ASX:TEA), Managing Director Stephen Young Lel Smits: Tasmea provides specialist trade services to the mining, energy, infrastructure and data centre sectors across Australia and has upgraded its FY27 earnings guidance after a record FY26 result. The group has completed the maximum JPS acquisitions and built a record […]
ECS Botanics (ASX:ECS): Exporting Australian medicinal cannabis brands to the UK
Transcription of The Stock Network Interview with ECS Botanics (ASX:ECS), Managing Director Nan-Maree Schoerie Lel Smits: ECS Botanics is a Victorian medicinal cannabis grower and manufacturer that turned EBITDA and operating cash flow positive in FY26 as its branded sales doubled. The company has just inked a deal with Curaleaf Laboratories to supply into the […]
Centuria Capital (ASX:CNI): Bringing private investors into larger unlisted property funds
Transcription of The Stock Network Interview with Centuria Capital (ASX:CNI), Co-Head of Unlisted Funds Stuart Wilton Lel Smits: Centuria Capital Group manages $22.2 billion of assets and its unlisted property funds raise capital from a network of more than 15,000 private investors. The group has just launched its largest single asset fund to date, seeded […]
Rivco Australia (ASX:RIV): Leasing water to irrigators as Murray supply tightens
Transcription of The Stock Network Interview with Rivco Australia (ASX:RIV), Executive Manager, Corporate Lachlan Campbell Lel Smits: Rivco Australia is the only ASX listed company giving investors direct access to Australian water entitlements with 61 gigalitres across the southern Murray-Darling Basin. Since bringing management in-house last November, the company has lifted the share of its […]
Solvar (ASX:SVR): Loan book growth, funding advantage and FY27 opportunity
Transcription of The Stock Network Interview with Solvar (ASX:SVR), CEO and Managing Director Scott Baldwin Lel Smits: Solvar, the specialist lender behind Money3, Automotive Financial Services, and Benji has entered the FY27 financial year with an Australian loan book above $1 billion for the first time. The group has more than $400 million of funding […]
Far East Gold (ASX:FEG): Answering Xingye’s claims & the vote that decides the board
Transcription of The Stock Network Interview with Far East Gold (ASX:FEG), CEO Shane Menere Izaac Ronay: Far East Gold is defending its board and its flagship Idenburg Gold project in Indonesia ahead of a shareholder vote next Wednesday, with proxies closing on Monday. Its largest shareholder, Xingye, failed with a takeover offer earlier this year and […]
Critica (ASX:CRI): Pairing Mt Lindsay tungsten with Jupiter rare earths across Australia
Transcription of The Stock Network Interview with Critica (ASX:CRI), Chairman Tim Lindley Lel Smits: Since we last had Critica on the Stock Network, the company has delivered a scoping study for its wholly-owned Mount Lindsay Tin-Tungsten project in Tasmania, outlining a modelled after-tax net present value of about $1 billion. It has also defined a first […]
EBR Systems (ASX:EBR): Securing higher Medicare payments for WiSE® & readying in-house manufacturing
Transcription of The Stock Network Interview with EBR Systems (ASX:EBR), Chief Corporate Development Officer Andrew Shute Lel Smits: EBR Systems continues its US rollout of the WISE CRT system, the world’s only wireless cardiac pacing device for heart failure. Since last speaking with the Stock Network in June, the number of physicians trained to implant […]
Imagion Biosystems (ASX:IBX): Opening US trial sites for MagSense® breast cancer imaging
Transcription of The Stock Network Interview with Imagion Biosystems (ASX:IBX), Chair Bob Proulx Lel Smits: Imagion Biosystems is testing MagSense, a non-radioactive imaging agent designed to help MRI scans detect cancer earlier and more precisely, starting with HER2-positive breast cancer. Since last speaking with the Stock Network in September, the company has secured central ethics […]